how-to-help

Support IAVI and help make the dream of a world without AIDS a reality. Donate Now

Donate

Your gift to the AIDS Vaccine Fund at IAVI will help make the dream of a world without AIDS a reality.

Click here for information on how to donate securities

Donations can be mailed to IAVI’s headquarters:

IAVI
Attn: AIDS Vaccine Fund
125 Broad Street, Floor 9
New York, NY 10004

212-847-1087
This email address is being protected from spambots. You need JavaScript enabled to view it.

Accountability

IAVI’s Goals
IAVI's mission is to ensure the development of safe, effective, accessible preventive HIV vaccines for use throughout the world. To that end, IAVI invests the bulk of its resources in the research, development and clinical assessment of candidate vaccines against subtypes of HIV that are prevalent in the developing world, where more than 95% of new HIV infections occur. For more, see What We Do.

Capacity to Make a Real Difference
IAVI is well positioned to rapidly move novel HIV vaccine candidates from the laboratory bench to clinical testing in the developing world. Our success comes in part from our end-to-end network of collaborating clinical research centers in Africa, in-house research laboratories and external academic, government and industry partners. Through our global policy and advocacy work, and with our network of partners in the field, IAVI works to mobilize a global effort to ensure that preventive AIDS vaccines are developed and delivered to all who need it. For more, see Progress.

Strategy for Success
The global search for a preventive AIDS vaccine poses enormous scientific and logistical challenges. To meet these challenges, IAVI integrates scientific and policy research, global advocacy and a unique, on-the-ground partnership-based approach called vaccine preparedness to help countries and communities involved in AIDS vaccine research and to generate support for such efforts.

IAVI will help advance the development of AIDS vaccines by:

  1. Adding value to the HIV vaccine field by identifying opportunities and gaps in vaccine discovery and development where IAVI capabilities can best be leveraged and add the most value
  2. Partnering to advance quality HIV vaccine candidates into clinical evaluation, shifting IAVI investment downstream over time
  3. Ensuring that investment in HIV prevention and AIDS vaccine R&D remain central to public policy and international health and development agendas by working in partnership with stakeholders and donors to ensure a strong voice for the field

Our guiding principles are leadership and collaboration, prioritization and focus, flexibility and speed, innovation, and global access to the fruits of IAVI’s endeavors. IAVI is also committed to fiscal discipline and to the transparent evaluation of our performance to ensure effectiveness and provide value for money.

Allocation of Revenue 
IAVI consistently demonstrates efficient management of resources, earning it Charity Navigator's three-star rating for good financial management, effectiveness and transparency. For more on IAVI’s financial information, see our financial data

2013 Expenses

Measuring Success
A safe, effective AIDS vaccine accessible to all is the ultimate indicator of success. This will take time, but there are key milestones to measure progress along the way. IAVI employs an industry-style approach to the evaluation of research and development progress at specific milestones to determine which programs will proceed and which will not. We also closely monitor the success of our efforts to build political and grass-roots support for AIDS vaccine development and promote government policies that foster innovation and increase investment in new biomedical tools for HIV prevention.

IAVI has finely honed systems for monitoring and evaluation at multiple levels. Multi-year milestones set benchmarks for organizational achievement. An annual Performance Scorecard calculates accomplishments against detailed organizational objectives, which are weighted by priority. A Monitoring and Evaluation system ensures specific activities advance IAVI’s objectives in an efficient and cost-effective manner. 

Reporting Progress
IAVI reports regularly to its Board of Directors, staff, independent committees and donors. Each year we publish an Annual Progress Report, that details key developments and work underway. IAVI is committed to an enhanced donor engagement strategy that demonstrates increased accountability, transparency and value for money.

IAVI staff publish widely in peer-reviewed journals, with importance assigned to open-access sources to reach the widest audiences. IAVI also is unique in reporting on progress in the broader AIDS vaccine field through our publications IAVI Report and VAX

Workplace Giving

CHARLOTTE RAYMOND, IAVIAn easy way to increase the impact of your gift

Employers are increasingly making it easier for employees to support the causes that mean the most to them—and offering programs that can increase the impact of their gifts.

Workplace campaigns 

Workplace campaigns allow you to donate to IAVI with a simple payroll deduction that will spread your gift over the course of the year, reflecting your steady commitment to the quest for an AIDS vaccine. 

Why give through a workplace campaign?

Ease. Workplace giving campaigns offer employees the chance to make a lasting commitment with a one-time pledge

Efficiency. Workplace campaigns help alleviate the burden of fundraising, leaving more resources available for programmatic work

Credibility. Global Impact (a workplace giving manager) represents more than 50 of the most respected United States-based international charities in workplace giving campaigns for federal employees and across the U.S. 

Impact. Small donations from many employees add up. Your employer may even match your donation, thereby increasing your contribution

IAVI’s Combined Federal Campaign code is 12173 and we are listed under AIDS Vaccine Initiative, International.  The code for state, local, and private-sector campaigns varies by campaign, so please look for IAVI or AIDS Vaccine Initiative in your campaign brochure, or check with your coordinator.

Corporate matching

Many companies match the contributions of their employees and their spouses, and retirees—a simple way to increase your gifts and become part of your organization’s philanthropic commitment. Companies know that matching charitable gifts is a meaningful demonstration of support for employees and their visions for a better world.

Your human resources department can tell you whether your company has a matching gift program. Ask for a matching gift form, complete it, and send it to IAVI at the address below with your donation. We will verify receipt of your gift and submit the form to your company.

IAVI
Attn: AIDS Vaccine Fund
125 Broad Street, Floor 9
New York, NY 10004

Please don’t pass up this opportunity to pass on your support in such a simple and powerful way.

Corporate Support

CRP 042611 461-no-shine webCharlotte Raymond/IAVISupport from our corporate partners is integral to our success; we simply could not do all we do without the sustained support of our corporate partners. IAVI believes that much can be achieved in our work through meaningful collaboration with the business sector. 

Corporate giving comes in many forms: grants restricted to a specific project, purpose or research area; unrestricted grants, which allow IAVI to direct the funding to areas where it is most urgently needed; corporate sponsorships; and donation of in-kind equipment, materials or services. 

Many corporations also support matching gift programs, which can amplify the philanthropic actions of their employees, and hasten progress toward the development of an effective and accessible HIV vaccine. 

We are always happy to explore ways to tailor opportunities to provide support that is mutually beneficial to IAVI and our corporate funders. Naming opportunities, for example, are an excellent way to achieve prominent recognition for your organization’s support for ending the AIDS pandemic. 

We take every opportunity to update and engage our corporate funders and keep them involved in our efforts. In addition to regular reporting, our funders are welcome to observe our work firsthand–by taking a tour of one of our labs: the AIDS Vaccine Design and Development Lab in New York; the IAVI Neutralizing Antibody Center at The Scripps Research Institute in La Jolla, Calif.; or the Human Immunology Laboratory in London, which works closely with several clinical research centers in sub-Saharan Africa.